SMi reports: An exciting panel discussion on ‘underlying principles of the EU internal market and competition policies’ is to be held at upcoming conference Parallel Trade. SMi’s Parallel Trade conference will be returning to London […]
NEC has the option for development and commercialization rights to the program worldwide, except for China and other Asian territories outside of Japan NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, […]
US researchers have launched a research network, Weill Neurohub, to develop treatments for brain and nervous system diseases and disorders. Weill Neurohub will involve neuroscientists and researchers from the University of California, Berkeley (UC Berkeley), […]
Japan-based Takeda Pharmaceutical has opened a new dengue vaccine manufacturing facility in Singen, Germany. The company will use the new manufacturing plant for formulation, fill, finish and secondary packaging of the TAK-003 tetravalent dengue vaccine […]
Boehringer Ingelheim and Eli Lilly have commenced first ever trial to evaluate Jardiance (empagliflozin) in people hospitalised for acute heart failure who have been stabilised. The Empulse, which is the sixth phase III study in […]